Page last updated: 2024-08-25

fluindione and Neoplasms

fluindione has been researched along with Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Fu, P; Li, J; Liu, C; Na, F; Pu, Y; Wei, W; Yang, L; Yi, C; Yin, T; Zhang, L; Zhao, Y1

Reviews

1 review(s) available for fluindione and Neoplasms

ArticleYear
Incidence and risk factors of acute kidney injury in cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis.
    Frontiers in immunology, 2023, Volume: 14

    Topics: Acute Kidney Injury; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Humans; Immune Checkpoint Inhibitors; Incidence; Ipilimumab; Neoplasms

2023